Is NCT05675865 recruiting in Baltimore, MD?

Yes, NCT05675865 is currently recruiting participants at its Baltimore, MD location. This sustained vt clinical trial is actively enrolling qualified participants.

How do I join the sustained vt clinical trial in Baltimore?

To join this clinical trial in Baltimore, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Baltimore clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Sustained VT Clinical Trial in Baltimore, MD

Who Can Participate

Inclusion Criteria

IC 1 Male or female ≥ 18 years

IC 2 Patients with a clinical indication for catheter ablation due to ischemic and/or non-ischemic heart disease and recurrent symptomatic sustained scar-mediated monomorphic Ventricular Tachycardia.

IC 3 Any of the following:

Ischemic cardiomyopapthy (ICM) patients with prior history of myocardial infarction with Q waves, focal wall motion abnormality on imaging, fixed perfusion defect correlating with coronary stenosis or prior coronary intervention, 20% ≤ LVEF \< 50%.

non-ischemic cardiomyopathy (NICM) patients with scar in a territory without coronary stenosis as evidenced by CMR imaging within the prior 90 days or intra-procedurally using EAM and PES prior to investigational device use, 20% ≤ LVEF \< 50%

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

IC 4 Has received a market-released ICD prior to enrollment

IC 5 Patient has had at least 1 documented spontaneous episode of SMVT within the previous 6 months

IC 6 Refractory to, or intolerant of, at least one Class III AAD. (Refractory or intolerant defined as AAD failure due to recurrent VT, not tolerated/ desired due to side effects)

IC 7 Willingness, ability, and commitment to participate in baseline and follow-up evaluations for the full length of the study

IC 8 Willingness and ability to give an informed consent

Exclusion Criteria

EC 1 Intracardiac thrombus by TTE or TEE within 48 hours prior to the procedure

EC 2 Presence of isolated epicardial scar(s) requiring epicardial ablation identified by either preoperative CMR imaging within 90 days of procedure or intra-procedurally using EAM and PES prior to investigational device use

EC 3 VTs due to any of the following causes:

Idiopathic VT

Automaticity or triggered activity

Bundle Branch Reentry (BBR)

Any focal tachycardia (e.g., papillary, RVOT)

Ventricular tachycardia secondary to electrolyte imbalance, active thyroid disease, or any other reversible or non-cardiac cause

EC 4 NICM patients only, if any of the following apply:

Congenital condition that limits access to the left or right ventricles

Severe aortic or mitral stenosis, severe mitral regurgitation, or severe aortic insufficiency

Active inflammatory processes (e.g., myocarditis) within the past 120 days

Sarcoidosis

Hypertrophic cardiomyopathy

Drug- or alcohol-induced cardiomyopathy

EC 5 Any VT ablation within 4 weeks prior to enrollment

EC 6 More than one prior (\>4 weeks) VT ablation or prior surgical treatment for VT within the past 2 years

EC 7 Cardiogenic shock, unless it is due to incessant monomorphic VT

EC 8 Any other cardiovascular conditions as described below:

Class IV heart failure

Aortic aneurysm

Previous cardiac surgery or percutaneous coronary intervention within 60 days prior to index procedure

Interatrial baffle, closure device, patch, or PFO occlusion device

Coronary artery bypass graft (CABG) procedure within six (6) months prior to the ablation procedure

Acute MI or unstable angina in the previous 60 days

Mechanical mitral or aortic valve

Cardiac myxoma

Significant congenital heart disease

EC 9 Acute illness or active systemic infection

EC 10 Any previous history of cryoglobulinemia

EC 11 History of blood clotting or bleeding disease

EC 12 Peripheral vascular disease that precludes LV access

EC 13 Contraindication to heparin

EC 14 Allergy to radiographic contrast dye that cannot be medically managed prior to the ablation procedure

EC 15 Any prior history of documented cerebral vascular accident (CVA), TIA or systemic embolism (excluding a post-operative Deep Vein Thrombosis, DVT), within 6 months prior to the ablation procedure.

EC 16 Pregnant, or anticipated pregnancy during study follow-up

EC 17 Current enrollment in any other study protocol where testing or results from that study may interfere with the procedure or outcome measurements for this study

EC 18 Any other condition (e.g., ARVC with extensive free wall scarring) that, in the judgment of the investigator, makes the patient a poor candidate for this procedure, the study or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, candidate for heart transplantation, patient with ventricular assist device, or terminal illness with a life expectancy less than 12 months)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT05675865) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sustained VT Treatment Options in Baltimore, MD

If you're searching for sustained vt treatment options in Baltimore, MD, this clinical trial (NCT05675865) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sustained vt specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sustained vt clinical trials near you to find additional studies recruiting in your area.

Sustained VT Clinical Trial in Baltimore, MD

Expert Care in Baltimore

IRB Approved

No-Cost Care

Apply for This Baltimore Location

Why Participate?

Simple Process

About This Sustained VT Study in Baltimore